Related Experiment Video
Updated: Sep 5, 2025

Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
RELA-induced MiR-21 Exerts Oncogenic Effects on PDAC via Targeting of ARHGAP24
Lanting Yu1,2, Jiawei Lu1,2, Haoran Xie1,2
1Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, China.
Abstract:
Inflammation is one of the inducing factors of pancreatic ductal adenocarcinoma (PDAC), and microRNAs have been confirmed to be involved in the occurrence and development of PDAC. However, whether RELA, an inflammatory regulator, is involved in the regulation of PDAC by miRNA remains to be further studied. In the present study miR-21 was characterized and its upstream regulatory mechanism was investigated, as well as its functional effects and target genes in pancreatic ductal adenocarcinoma (PDAC). In situ hybridization analysis confirmed increased miR-21 expression levels in PDAC tissues. The results of the chromatin immunoprecipitation and dual-luciferase reporter assays demonstrated that transcription factor RELA modulated miR-21 transcription in the PDAC, PANC-1 and MIA PaCa-2 cell lines. Subsequently, a cell viability assay, EdU staining assay and flow cytometry analysis, demonstrated that miR-21 promoted cell proliferation and cell cycle progression, but inhibited cell apoptosis in vitro. Furthermore, a xenograft assay demonstrated that miR-21 accelerated tumor growth in vivo. Mechanistically, miR-21 directly regulated the expression of Rho GTPase activating protein 24 (ARHGAP24), which was indicated to be a tumor suppressor gene. Moreover, both miR-21 and ARHGAP24 were strongly associated with clinical features and may therefore serve as valuable biomarkers in PDAC prognosis.
Insights
RELA promotes pancreatic cancer by increasing miR-21, which drives tumor growth and inhibits apoptosis. This miR-21 targets ARHGAP24, a tumor suppressor, highlighting their potential as pancreatic ductal adenocarcinoma (PDAC) biomarkers.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Inflammation is a known factor in pancreatic ductal adenocarcinoma (PDAC) development.
- MicroRNAs (miRNAs) play a role in PDAC occurrence and progression.
- The involvement of the inflammatory regulator RELA in miRNA-mediated PDAC regulation requires further investigation.
Purpose of the Study:
- To investigate the role of miR-21 in pancreatic ductal adenocarcinoma (PDAC).
- To elucidate the upstream regulatory mechanism of miR-21 involving RELA.
- To determine the functional effects and target genes of miR-21 in PDAC.
Main Methods:
- In situ hybridization to assess miR-21 expression in PDAC tissues.
- Chromatin immunoprecipitation and dual-luciferase reporter assays to confirm RELA's regulation of miR-21.
- In vitro assays (cell viability, EdU staining, flow cytometry) and in vivo xenograft assays to evaluate miR-21's functional effects.
- Analysis of miR-21's direct target gene, ARHGAP24.
Main Results:
- miR-21 expression is increased in PDAC tissues.
- Transcription factor RELA directly modulates miR-21 transcription in PDAC cell lines.
- miR-21 promotes cell proliferation and cell cycle progression while inhibiting apoptosis in vitro.
- miR-21 accelerates tumor growth in vivo.
- miR-21 directly targets and downregulates the tumor suppressor gene ARHGAP24.
Conclusions:
- RELA-mediated upregulation of miR-21 contributes to PDAC progression.
- miR-21 promotes PDAC by inhibiting apoptosis and enhancing proliferation.
- ARHGAP24 is a tumor suppressor targeted by miR-21 in PDAC.
- Both miR-21 and ARHGAP24 show strong associations with clinical features and may serve as valuable prognostic biomarkers for PDAC.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

